NPI: 1144514662 · KANNAPOLIS, NC 28083 · Family Medicine Physician · NPI assigned 06/01/2011
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 06/01/2011 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,568 | $108K |
| 2019 | 3,042 | $111K |
| 2020 | 1,112 | $73K |
| 2021 | 3,951 | $97K |
| 2022 | 10,856 | $134K |
| 2023 | 13,926 | $101K |
| 2024 | 18,089 | $52K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,698 | 5,836 | $428K |
| 99199 | Unlisted special service, procedure or report | 42,811 | 42,006 | $144K |
| 99215 | Prolong outpt/office vis | 789 | 733 | $51K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 876 | 725 | $43K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 150 | 141 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 201 | 195 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 47 | 45 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 102 | 67 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 18 | 16 | $872.27 |
| 90686 | 145 | 139 | $866.93 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 30 | 15 | $423.90 |
| 96127 | 75 | 53 | $308.75 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 13 | 12 | $169.56 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | 13 | $84.48 |
| G8484 | Influenza immunization was not administered, reason not given | 67 | 61 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 587 | 535 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 773 | 718 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 55 | 53 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 145 | 138 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 44 | 43 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 13 | 12 | $0.00 |
| G8732 | No documentation of pain assessment, reason not given | 684 | 631 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 137 | 130 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 445 | 411 | $0.00 |
| 3017F | 76 | 72 | $0.00 | |
| 1036F | 256 | 235 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 73 | 70 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 221 | 212 | $0.00 |